WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 5'7301 Infant (under 12 months) mortality rate: 62
GDP / capita (US$): 12'3741 Child (under 5 years) mortality rate: 72

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 9'511  9'553  9'597  9'647  9'702  10'272  9'735  9'057 
Births 93  94  96  97  99  122  147  170 
Surviving infants 92  93  95  96  98  121  144  164 
Pop. less than 5 years 472  481  491  503  512  613  759  814 
Pop. less than 15 years 1'543  1'567  1'595  1'627  1'657  2'075  2'367  2'223 
Female 15-49 years 2'309  2'326  2'344  2'361  2'387  2'614  2'367  2'312 

Number of reported case

(Click for retrospective incidence data for Serbia)
Diphtheria
Japanese encephalitis
Measles 370  20  38  4'978  37'441 
Mumps 64  584  63  40  262  1'215 
Pertussis 39  51  25  24  1'440  6'710 
Polio*
Rubella 11  14  14  14  27  2'188 
Rubella (CRS)
Tetanus (neonatal) 17 
Tetanus (total) 24  57  99 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Serbia)
Vaccine year result method % card seen                                                
BCG 2004  75  MICS   71  97  98  99  99  98  100 
DTP1 2004  99  MICS   71  98 
DTP3 2004  96  MICS   71  95  91  94  91  95  95 
HepB_BD          99 
HepB3          91  97  94  81  93 
Hib3          92  90  93  91  94 
JapEnc         
MCV 2004  87  MICS   71  92  87  93  95  95  89 
MCV2          82  90  90  91  87 
PCV1         
PCV3         
Pol3 2004  94  MICS   71  97  93  94  91  97  98 
Rota1         
Rota_last         
Rubella1          93 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Serbia)
BCG 97  98  99  99  98  85 
DTP1 98  91  98  91  98  97 
DTP3 95  91  94  91  95  95 
HepB3 91  97  94  89  93 
HepB_BD 99  99  99  99  99 
Hib3 92  90  93  91  94 
MCV 92  87  93  95  95  89 
MCV2 82  90  90  91  87  78 
PnC3
Pol3 97  93  94  91  97  98 
Rota_last

Number of districts in the country 25  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 7 years; Yes
DTwP 8, 14, 20 weeks; 18 months; Yes
HIB 8, 14, 20 weeks; Yes
HepAHepB Yes travelers
HepB birth; 4 weeks; 5 months; 12 years; Yes
IPV > 12 months; Immunideficient patients
Influenza >65 years; Yes chronic diseases patients
MMR 12 months; 7 years; Yes
MenAC some chronic diseases patients, travelers
OPV 8, 14, 20 weeks; 18 months; 7, 14 years; Yes
Pneumo_ps some chronic diseases patients
Td 14 years; Yes
Typhoid travelers
YF travelers

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR         Yes    No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number         25     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR              

System performance

Total Nº districts in country number 25  25  25  25  25  25  25 
Nº districts with DTP3 coverage >=80% number 25  25  25  25  25  25 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 16  13  22  16  22  21   
% of districts with MCV1 coverage >=95% From 0 to 100% 64  52  88  64  88  84   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%         100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.